ଓଭାରିଆନ୍ କ୍ୟାନ୍ସର
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୧ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛି।
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
Peritoneal carcinomatosis is a common event in the natural history of colorectal and other digestive tract cancers. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising therapeutic option for highly selected patients with peritoneal carcinomatosis arising from different malignancies such as colorectal cancer, gastric cancer, ovarian cancer, or peritoneal mesothelioma with improvement of both patient survival and quality of life. CRS, i.e., removal of all visible metastatic abdominal and pelvic disease with peritonectomy along with HIPEC (for 90…
Sponsor: ଟାଟା ମେମୋରିଆଲ ସେଣ୍ଟର
ClinicalTrials.gov ରେ NCT02754115
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ 21 ନଭେମ୍ବର 2024 · ଆମ ଦ୍ୱାରା ପଢାଯାଇଛି 20 ଅକ୍ଟୋବର 2026